What types of peptides does Thinheal supply?

Thinheal supplies generic peptide APIs, therapeutic peptides, GLP-1 analogues such as Semaglutide (CAS 910463-68-2), GLP-2 analogues, other gastrointestinal peptides, other therapeutic peptide APIs and cosmetic peptides for skin-care formulations.

Does Thinheal offer custom peptide development and CDMO services?

Yes. Thinheal provides project-based contract research and development, contract manufacturing and sales support, covering custom peptide development, process optimization, scale-up and commercial API supply through to formulation development.

What is Thinheal's production capacity?

Thinheal operates an R&D center and a production base in Hangzhou, China. Total production capacity for chemically synthesized peptides has reached the multi-ton level.

What documentation can buyers expect?

Each shipment is accompanied by batch analytical data such as a Certificate of Analysis. Additional documents required for supplier qualification or regulatory filings can be scoped with the sales and technical team for each project.

How do international buyers contact the right sales team?

Thinheal runs regional sales desks for USA & Europe, Russia & CIS & Europe, Asia, and the Middle East & East Asia. Buyers can also email info@thinheal.com or call +86 0571-86758863.

High-Quality Survodutide CAS: 2805997-46-8 Quotes, Pricelist

1 / 2

High-Quality Survodutide CAS: 2805997-46-8 Quotes, Pricelist

Send Inquiry

Product Description

Mechanism & Efficacy

Survodutide is a peptide compound designed as a GLP‑1/GIP/glucagon multi‑receptor agonist under clinical investigation for potential benefits in metabolic regulation, weight management, and glucose control. It is being evaluated in clinical studies for its unique balanced receptor agonism profile.

Dosage & Research Use

Typical Human Clinical Dose (Investigational)

Once‑weekly subcutaneous administration is the regimen used in human Phase 2/3 studies.
Commonly studied doses include 2 mg, 4 mg, 6 mg, and 8 mg per week, with dose escalation based on tolerability and clinical endpoints.
These doses are for research purposes only and should only be administered under authorized clinical protocols.

Patent & Intellectual Property

Unlike some established peptide drugs with long‑standing granted patents, Survodutide’s patent landscape is still evolving. Careful review of publicly available patent databases reveals pending patent applications related to multi‑agonist peptide compositions and methods of use, but no single fully granted, composition‑of‑matter patent for Survodutide with a confirmed expiration date is currently available in the public domain.

Quality & Compliance

Survodutide is manufactured in a cGMP‑aligned facility, with comprehensive quality control covering identity verification, purity testing and stability analysis, ensuring research‑grade quality that meets laboratory and industrial standards.

Customer Service & Shipping

ThinHeal provides comprehensive technical documentation (CoA, MSDS), pre‑shipment quality verification, smart cold‑chain shipping solutions, and global logistics tracking support. After delivery, we offer storage guidance and experimental planning assistance to ensure your research projects proceed smoothly.

Frequently Asked Questions (FAQ)

1. What is Survodutide and how does it function?

Survodutide is an investigational peptide compound acting as a GLP-1/GIP/glucagon multi-receptor agonist, designed for potential application in metabolic regulation, glucose control, and weight management.

2. What are the typical investigational dosages used in clinical trials?

In Phase 2/3 clinical research, doses such as 2 mg, 4 mg, 6 mg, and 8 mg administered subcutaneously once per week are studied under specific dose escalation protocols.

3. What is the intellectual property and patent status of Survodutide?

Survodutide's patent profile is actively evolving with pending patent applications for multi-agonist peptide compositions, but no single fully granted composition-of-matter patent with a confirmed expiration date is currently listed in public databases.

4. How is the quality of Survodutide validated?

It is manufactured in a cGMP-aligned facility using complete quality control standards including purity testing, identity verification, and stability analysis to meet laboratory and industrial requirements.

5. What shipping and technical support services are provided by ThinHeal?

ThinHeal offers full technical documentation (CoA, MSDS), pre-shipment quality verification, smart cold-chain shipping solutions, global logistics tracking, as well as post-delivery storage and experimental guidance.